Skip to main content
SpringerLink
Log in

Multidrug-resistant Tuberculosis

  • Book
  • © 2000

Overview

Editors:
  1. Ivan Bastian

    1. Mycobacterium Reference Laboratory, Institute of Medical & Veterinary Science, Adelaide, Australia

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Françoise Portaels

    1. Mycobacteriology Unit, Institute of Tropical Medicine, Antwerp, Belgium

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Resurgent and Emerging Infectious Diseases (REID, volume 1)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (19 chapters)

  1. Front Matter

    Pages i-xv
    Download chapter PDF

  2. Introduction

    • Ivan Bastian, Françoise Portaels
    Pages 1-15

  3. The epidemiology of multidrug-resistant tuberculosis in the United States and other established market economies

    • Marisa Moore, Eugene McCray, Ida M. Onorato
    Pages 17-28

  4. Epidemiology of multidrug-resistant tuberculosis in low- and middle-income countries

    • Marcos A. Espinal
    Pages 29-44

  5. The interaction of human immunodeficiency virus and multidrug-resistant Mycobacterium tuberculosis

    • Eugene McCray, Ida M. Onorato
    Pages 45-57

  6. Clinical mismanagement and other factors producing antituberculosis drug resistance

    • Ariel Pablos-Méndez, Klaus Lessnau
    Pages 59-76

  7. The molecular mechanisms of drug resistance in Mycobacterium tuberculosis

    • Howard E. Takiff
    Pages 77-114

  8. DOTS and multidrug-resistant tuberculosis

    • Mario C. Raviglione
    Pages 115-131

  9. Conventional methods for antimicrobial susceptibility testing of Mycobacterium tuberculosis

    • Leonid Heifets
    Pages 133-143

  10. Novel rapid antimicrobial susceptibility tests for Mycobacterium tuberculosis

    • Juan Carlos Palomino
    Pages 145-162

  11. Pharmacology of the second-line antituberculosis drugs

    • Charles A. Peloquin, Barbara Auclair
    Pages 163-174

  12. Treatment of multidrug-resistant tuberculosis

    • Michael D. Iseman, Gwen A. Huitt
    Pages 175-190

  13. Treatment of multidrug-resistant tuberculosis in developing countries

    • John Crofton, Armand Van Deun
    Pages 191-203

  14. Treatment outcome of multidrug-resistant tuberculosis

    • Edward E. Telzak
    Pages 205-212

  15. Chemoprophylaxis and BCG in contacts of multidrugresistant tuberculosis

    • Richard A. Stapledon, Richard Lumb, Irene S. Lim
    Pages 213-224

  16. Multidrug-resistant tuberculosis and the health care worker

    • David M. Weinstock, Kent A. Sepkowitz
    Pages 225-239

  17. The development of new chemotherapeutics for multidrug-resistant tuberculosis

    • Clifton E. Barry III
    Pages 241-252

  18. Population dynamics and control of multidrug-resistant tuberculosis

    • Christopher Dye, Brian G. Williams
    Pages 253-267

  19. Administrative, engineering, and personal protective measures for controlling Mycobacterium tuberculosis

    • Chesley Richards, William R. Jarvis
    Pages 269-284

  20. Making DOTS-Plus work

    • Paul E. Farmer, Sonya S. Shin, Jaime Bayona, Jim Y. Kim, Jennifer J. Furin, Joel G. Brenner
    Pages 285-306
Back to top

Keywords

About this book

Multidrug-resistant tuberculosis: past, present and future Ivan Bastian and Franyoise Portaels Mycobacteriology Unit. Institute of Tropical Medicine. Antwerp. Belgium The Lord hath created medicines out of the earth and he that is wise will not abhor them. Ecclesiasticus 38:4, quoted by Selman Waksman when accepting the 1952 Nobel Prize for Medicine that was awarded for the discovery of the first effective antituberculosis drug. streptomycin. which was derived from the soil bacterium, Streptomyces grisells. 1. HISTORICAL PERSPECTIVE This book has been published at the close of the twentieth century when the medical profession and the general community are increasingly concerned about the threat of multidrug-resistant tuberculosis (MDRTB)[1. 2]. However, at this epoch, it is enlightening to move back from our immediate concerns about MDRTB 'hot spots' in Asia, South America, and the former Soviet Union [3], and to place our current predicament in an historical context. If the results of the global survey of antituberculosis drug resistance conducted by the World Health Organisation (WHO) and the International Union against Tuberculosis and Lung Disease (IUATLD) can be extrapolated, only 2. 2% of TB cases worldwide are due to multi drug­ resistant strains [3]. At the beginning of the 20th century, all TB cases were refractory to all available therapies. Great advances had been made during the 19th century in the understanding of the epidemiology and pathogenesis of TB, and in the diagnosis of the disease (reviewed in references 4-7).

Editors and Affiliations

  • Mycobacterium Reference Laboratory, Institute of Medical & Veterinary Science, Adelaide, Australia

    Ivan Bastian

  • Mycobacteriology Unit, Institute of Tropical Medicine, Antwerp, Belgium

    Françoise Portaels

Bibliographic Information

  • Book Title: Multidrug-resistant Tuberculosis

  • Editors: Ivan Bastian, Françoise Portaels

  • Series Title: Resurgent and Emerging Infectious Diseases

  • DOI: https://doi.org/10.1007/978-94-011-4084-3

  • Publisher: Springer Dordrecht

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media Dordrecht 2000

  • Hardcover ISBN: 978-0-7923-6169-5Published: 30 June 2000

  • Softcover ISBN: 978-94-010-5794-3Published: 05 November 2012

  • eBook ISBN: 978-94-011-4084-3Published: 06 December 2012

  • Series ISSN: 1568-1041

  • Edition Number: 1

  • Number of Pages: XV, 312

  • Topics: Infectious Diseases, Internal Medicine

Publish with us

Policies and ethics

Back to top

Search

Navigation